Shelf life (days): 1460
Info: A crystalline solid form of latanoprost (free acid); selectively binds to the FP receptor (Ki = 0.098 µM) over the EP1, EP1, EP3, and EP4 receptors (Kis = 2.06, 39.667, 7.519, and 75 µM, respectively), as well as the DP, IP, and TP receptors (Kis = ≥20, ≥90, and ≥60 µM, respectively); induces phosphoinositide turnover in isolated human ciliary muscle and human trabecular meshwork cells, mouse NIH3T3 fibroblasts, and rat A7r5 vascular smooth muscle cells, which all endogenously express FP receptors (EC50s = 124, 35, 32, and 35 nM, respectively), as well as HEK293 cells expressing human ocular FP receptors (EC50 = 45.7 nM); increases intracellular calcium levels in hEP1-5/293-AEQ17 cells expressing EP1 receptors in an aequorin-based calcium assay (EC50 = 119 nM); induces contraction of isolated cat iris sphincter smooth muscle (EC50 = 29.9 nM)
Formulation: A solid
Formal Name: (Z)-7-((1R,2R,3R,5S)-3,5-dihydroxy-2-((R)-3-hydroxy-5-phenylpentyl)cyclopentyl)hept-5-enoic acid, L-arginine salt
Purity: ≥95%
Formula Markup: C29H48N4O7
Formula Weight: 564.8
English
Deutsch
